← Back to Intel
Insider ActivityAGIO
Viswanadhan Krishnan, Chief Corp Dev & Strategy at AGIOS PHARMACEUTICALS, INC., sold $103K of AGIO
Updated Jun 11, 2026
Viswanadhan Krishnan
Chief Corp Dev & Strategy
AGIOS PHARMACEUTICALS, INC. ·
$AGIO
Transaction Details
| Insider | Viswanadhan Krishnan |
|---|---|
| Title | Chief Corp Dev & Strategy |
| Company | AGIOS PHARMACEUTICALS, INC. |
| Ticker | AGIO |
| Transaction Type | Sale |
| Transaction Date | 2026-04-02 |
| Shares Traded | 2,959 |
| Price Per Share | $34.71 |
| Total Value | $103K |
| Filed Date | 2026-04-06 |
| Accession Number | 0001439222-26-000059 |
Ownership Context
| Shares Owned After Transaction | 10,282 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001439222-26-000059
Other Insider Trades — AGIO
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Burns James William | Chief Legal Officer | traded | — | 2026-04-02 |
| Burns James William | Chief Legal Officer | sold | $114K | 2026-04-02 |
| Jones Cecilia | Chief Financial Officer | traded | — | 2026-04-02 |
| Jones Cecilia | Chief Financial Officer | sold | $109K | 2026-04-02 |
| Gheuens Sarah | Chief Medical Officer | traded | — | 2026-04-02 |
| Gheuens Sarah | Chief Medical Officer | sold | $102K | 2026-04-02 |
| Goff Brian | Chief Executive Officer, Director | traded | — | 2026-04-02 |
| Goff Brian | Chief Executive Officer, Director | sold | $433K | 2026-04-02 |
| Goff Brian | Chief Executive Officer, Director | traded | — | 2026-04-02 |
| Goff Brian | Chief Executive Officer, Director | sold | $229K | 2026-04-02 |
Other Trades by Viswanadhan Krishnan
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| AGIO | AGIOS PHARMACEUTICALS, INC. | traded | — | 2026-04-02 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for AGIO — AGIOS PHARMACEUTICALS, INC. →
Track AGIO insider activity in real time on The Wire →
Get alerts when Viswanadhan Krishnan files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 11, 2026 at 07:21 UTC